Search results
Jan 12, 2021 · ClearMind Biomedical has received FDA clearance for its novel neuroendoscope, the Axonpen System, for illumination and visualization of intracranial tissue and fluids, and the controlled aspiration of tissue and/or fluid during surgery. Requiring only a narrow channel of 6.5mm through the skull for insertion into the brain, the steerable ...
Jul 14, 2022 · On July 8, 2022, ClearMind Biomedical, one of the leaders in the medical device industry, completed its First in Man (FIM) clinical trial in Taiwan for a neurosurgical endoscope, the Axonpen System. The trail was completed with exceptional results. The Axonpen System is the most integrated minimally invasive neurosurgical tool, combining over ...
Date Received: 05/15/2020: Decision Date: 11/27/2020: Decision: Substantially Equivalent (SESE) Regulation Medical Specialty: Neurology
Jan 11, 2021 · ClearMind Biomedical announced today that it received FDA clearance for its Axonpen novel neuroendoscope system.. Los Angeles-based ClearMind Biomedical’s Axonpen system is designed for the ...
OurTeam. Together, we work closely with neurologist, neurosurgeon, interventional radiologist, rehabiliation specilaist, emergency doctors, and many key opinion leaders world wide to make a difference and formulate the ultimate stroke solution!
Jan 12, 2021 · 12 January 2021. ClearMind Biomedical has announced 510 (K) US Food and Drug Administration (FDA) clearance for its Axonpen System, which is used for the illumination and visualisation of intracranial tissue and fluids, and the controlled aspiration of tissue and/or fluid during surgery. According to ClearMind, the Axonpen System supports a ...
Nov 28, 2023 · Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems ...
